The Children’s Health Insurance Program (CHIP) was funded for 6 years, through fiscal year (FY) 2023, under a deal worked out between Senate Majority Leader Mitch McConnell, R-Kentucky, and Senate Minority Leader Charles Schumer, D-New York.
The Children’s Health Insurance Program (CHIP) was funded for 6 years, through fiscal year (FY) 2023, under a deal worked out between Senate Majority Leader Mitch McConnell, R-Kentucky, and Senate Minority Leader Charles Schumer, D-New York.
The CHIP funding was included as part of a stopgap spending measure to reopen the US government and allow federal employees back to work as early as Tuesday. The stopgap measure expires February 8.
Senators voted 81-18 to approve the measure after McConnell promised to allow an immigration bill to reach the floor next month. After the Senate vote, the House voted on it again, and it headed to President Donald Trump’s desk, who could sign it Monday night.
Senate Finance Committee Chairman Orrin Hatch, R-Utah, also said in a statement the bill passed by the Senate delays 3 taxes included in the Affordable Care Act: the medical device tax through 2019, the so-called Cadillac tax through 2021, and the Health Insurance Tax (HIT) in 2019.
The Cadillac tax is a 40% excise tax on employer plans exceeding $10,200 in premiums per year for individuals and $27,500 for families. The HIT is paid by small businesses that cannot self-insure, like large corporations. The 2.3% medical device tax is already delayed.
CHIP, which expired on September 30, 2017, covers 8.9 million children through Medicaid or other state-administered plans. Despite a history of bipartisan support from Congress, the legislature passed only a $2.85 billion allocation in December. The money was intended to last until March, but most states were slated to run out of funds by February 1.
CHIP, which is jointly funded by states and the federal government, would see an enhanced federal matching rate at 23% through FY 2019, change to 11.5% for FY 2020, and return to 0% or a traditional CHIP matching rate for fiscal years 2021, 2022 and 2023.
Hatch said it would also create protections and flexibility under the maintenance-of-effort provision.
In a statement, Colleen Kraft, MD, FAAP, president of the American Academy of Pediatrics, applauded the bipartisan action "after 114 days of worry" and called for additional action on maternal and child health. “Now that Congress has acted on CHIP, we urge a similar bipartisan approach to the other pressing child health issues that remain unresolved, such as the Maternal Infant, and Early Childhood Home Visiting Program (MIECHV), which serves at-risk pregnant women and parents with young children. We also call on lawmakers to find a permanent solution that will allow Dreamers—immigrants brought to the United States as children and who are now young adults—to remain in the United States."
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More